Analysts Says ‘Don’t Buy The Big Banks,’ Deutsche Bank Cuts Rating
Deutsche Bank downgraded Bank of America Corp (NYSE: BAC) and JPMorgan Chase & Co (NYSE: JPM)
Stock Market Pops After Latest Jobs Report, But New Data Shows Key Sectors Contracting
On Friday morning, the U.S. Labor Department released the latest jobs report for the month of December, and the stock market took the news positively.
Immunome Stock Jumps On Discovery Pact With AbbVie
AbbVie Inc (NYSE:ABBV) and Immunome Inc (NASDAQ:IMNM) announced a worldwide collaboration and option agreement to discover up to 10 novel antibody-target pairs arising…
Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow
Walgreens Boots Alliance Inc (NASDAQ:WBA) is reportedly the first major national pharmacy chain to say it plans to dispense…
Goldman Sachs’ Four Zones Within Capital Market Coverage, Gives Stock Picks
Goldman Sachs Group Inc (NYSE: GS) has outlined four themes for 2023 amid recessionary risks and rising interest rates.
Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another
The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst adjusted his coverage of two large cap pharmaceutical stocks heading into what could be a volatile 2023.
Justice Department Convicts New York Person For Stealing General Electric Trade Secrets For China
The U.S. Justice Department said that a New York man was convicted for conspiring to steal General Electric Company's (NYSE: GE) trade secrets to benefit China.
FDA Permits Retail Pharmacies To Distribute Abortion Pills, Expanding Access After Supreme Court Ruling
The FDA will allow pharmacies to offer abortion pills, mifepristone, in the U.S. Pharmacies must complete a form for certification…
Sanofi Forecasts Foreign Exchange, Record Flu Vaccine Sales To Boost Q4 Earnings
As Sanofi SA (NASDAQ:SNY) schedules to report Q4 FY22 earnings early next month, it expects a positive currency impact in Q4 2022.…
Goldman Sachs Bullish On M&A Deals Activity Picking Up In Late 2023
Goldman Sachs Group Inc (NYSE: GS) seems to be bullish on the recovery of global mergers & acquisition deals in the second half of 2023 despite slow economic growth and a weak credit market.